Extensive characterization of NF-κB binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits

Genome Biology

Volumn 12, Issue 7, 2011, Pages

  Wong, Daniel ^a   Teixeira, Ana ^a   Oikonomopoulos, Spyros ^a   Humburg, Peter ^a   Lone, Imtiaz N ^b   Saliba, David ^c   Siggers, Trevor ^d   Bulyk, Martha ^d,e   Angelov, Dimitar ^b   Dimitrov, Stefan ^f   Udalova, Irina A ^c   Ragoussis, Jiannis ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ DE LYON   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^f UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; GEL MOBILITY SHIFT ASSAY; GENETIC FUNCTIONAL TRAIT; GENETIC RISK; GENETIC TRAIT; NUCLEOTIDE SEQUENCE; PROTEIN DNA BINDING; PROTEIN MICROARRAY; PROTEIN MOTIF; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BINDING SITE; CONSENSUS SEQUENCE; GENETIC ASSOCIATION; HUMAN; METABOLISM; NUCLEOTIDE MOTIF; QUANTITATIVE TRAIT LOCUS;

ALLELES; BASE SEQUENCE; BINDING SITES; CONSENSUS SEQUENCE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NF-KAPPA B; NUCLEOTIDE MOTIFS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ARRAY ANALYSIS; QUANTITATIVE TRAIT LOCI;

EID: 79960860669     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2011-12-7-r70     Document Type: Article

References (52)

1. Ge B, Pokholok DK, Kwan T, Grundberg E, Morcos L, Verlaan DJ, Le J, Koka V, Lam KC, Gagne V, Dias J, Hoberman R, Montpetit A, Joly MM, Harvey EJ, Sinnett D, Beaulieu P, Hamon R, Graziani A, Dewar K, Harmsen E, Majewski J, Goring HH, Naumova AK, Blanchette M, Gunderson KL, Pastinen T. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet 2009, 41:1216-1222. 10.1038/ng.473, 19838192.
2. Pastinen T. Genome-wide allele-specific analysis: insights into regulatory variation. Nat Rev Genet 2010, 11:533-538.
3. Farnham PJ. Insights from genomic profiling of transcription factors. Nat Rev Genet 2009, 10:605-616. 10.1038/nrg2636, 2846386, 19668247.
4. Zheng W, Zhao H, Mancera E, Steinmetz LM, Snyder M. Genetic analysis of variation in transcription factor binding in yeast. Nature 2010, 464:1187-1191. 10.1038/nature08934, 2941147, 20237471.
5. McDaniell R, Lee BK, Song L, Liu Z, Boyle AP, Erdos MR, Scott LJ, Morken MA, Kucera KS, Battenhouse A, Keefe D, Collins FS, Willard HF, Lieb JD, Furey TS, Crawford GE, Iyer VR, Birney E. Heritable individual-specific and allele-specific chromatin signatures in humans. Science 2010, 328:235-239. 10.1126/science.1184655, 2929018, 20299549.
6. Kasowski M, Grubert F, Heffelfinger C, Hariharan M, Asabere A, Waszak SM, Habegger L, Rozowsky J, Shi M, Urban AE, Hong MY, Karczewski KJ, Huber W, Weissman SM, Gerstein MB, Korbel JO, Snyder M. Variation in transcription factor binding among humans. Science 2010, 328:232-235. 10.1126/science.1183621, 2938768, 20299548.
7. Gordan R, Hartemink AJ, Bulyk ML. Distinguishing direct versus indirect transcription factor-DNA interactions. Genome Res 2009, 19:2090-2100. 10.1101/gr.094144.109, 2775597, 19652015.
8. Jolma A, Kivioja T, Toivonen J, Cheng L, Wei G, Enge M, Taipale M, Vaquerizas JM, Yan J, Sillanpaa MJ, Bonke M, Palin K, Talukder S, Hughes TR, Luscombe NM, Ukkonen E, Taipale J. Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificities. Genome Res 2010, 20:861-873. 10.1101/gr.100552.109, 2877582, 20378718.
9. Robertson AG, Bilenky M, Tam A, Zhao Y, Zeng T, Thiessen N, Cezard T, Fejes AP, Wederell ED, Cullum R, Euskirchen G, Krzywinski M, Birol I, Snyder M, Hoodless PA, Hirst M, Marra MA, Jones SJ. Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. Genome Res 2008, 18:1906-1917. 10.1101/gr.078519.108, 2593584, 18787082.
10. Badis G, Chan ET, van Bakel H, Pena-Castillo L, Tillo D, Tsui K, Carlson CD, Gossett AJ, Hasinoff MJ, Warren CL, Gebbia M, Talukder S, Yang A, Mnaimneh S, Terterov D, Coburn D, Li Yeo A, Yeo ZX, Clarke ND, Lieb JD, Ansari AZ, Nislow C, Hughes TR. A library of yeast transcription factor motifs reveals a widespread function for Rsc3 in targeting nucleosome exclusion at promoters. Mol Cell 2008, 32:878-887. 10.1016/j.molcel.2008.11.020, 2743730, 19111667.
11. Bulyk ML, Gentalen E, Lockhart DJ, Church GM. Quantifying DNA-protein interactions by double-stranded DNA arrays. Nat Biotechnol 1999, 17:573-577. 10.1038/9878, 10385322.
12. Ge H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res 2000, 28:e3. 10.1093/nar/28.2.e3, 102535, 10606671.
13. Linnell J, Mott R, Field S, Kwiatkowski DP, Ragoussis J, Udalova IA. Quantitative high-throughput analysis of transcription factor binding specificities. Nucleic Acids Res 2004, 32:e44. 10.1093/nar/gnh042, 390317, 14990752.
14. Zykovich A, Korf I, Segal DJ. Bind-n-Seq: high-throughput analysis of in vitro protein-DNA interactions using massively parallel sequencing. Nucleic Acids Res 2009, 37:e151. 10.1093/nar/gkp802, 2794170, 19843614.
15. Stormo GD, Zhao Y. Determining the specificity of protein-DNA interactions. Nat Rev Genet 2010, 11:751-760.
16. Beinke S, Ley SC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 2004, 382:393-409. 10.1042/BJ20040544, 1133795, 15214841.
17. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 2006, 25:6800-6816. 10.1038/sj.onc.1209938, 17072329.
18. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006, 25:6680-6684. 10.1038/sj.onc.1209954, 17072321.
19. Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene 2006, 25:6758-6780. 10.1038/sj.onc.1209943, 17072327.
20. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734. 10.1038/nri910, 12360211.
21. Udalova IA, Mott R, Field D, Kwiatkowski D. Quantitative prediction of NF-kappa B DNA-protein interactions. Proc Natl Acad Sci USA 2002, 99:8167-8172. 10.1073/pnas.102674699, 123039, 12048232.
22. Chen FE, Kempiak S, Huang DB, Phelps C, Ghosh G. Construction, expression, purification and functional analysis of recombinant NFkappaB p50/p65 heterodimer. Protein Eng 1999, 12:423-428. 10.1093/protein/12.5.423, 10360983.
23. Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature 1998, 391:410-413. 10.1038/34956, 9450761.
24. Badis G, Berger MF, Philippakis AA, Talukder S, Gehrke AR, Jaeger SA, Chan ET, Metzler G, Vedenko A, Chen X, Kuznetsov H, Wang CF, Coburn D, Newburger DE, Morris Q, Hughes TR, Bulyk ML. Diversity and complexity in DNA recognition by transcription factors. Science 2009, 324:1720-1723. 10.1126/science.1162327, 2905877, 19443739.
25. Gene Expression Omnibus. , http://www.ncbi.nlm.nih.gov/geo/
26. Roulet E, Busso S, Camargo AA, Simpson AJ, Mermod N, Bucher P. High-throughput SELEX SAGE method for quantitative modeling of transcription-factor binding sites. Nat Biotechnol 2002, 20:831-835.
27. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
28. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 2000, 20:9113-9119. 10.1128/MCB.20.24.9113-9119.2000, 102169, 11094063.
29. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999, 22:145-150. 10.1038/9649, 10369255.
30. Chen YQ, Ghosh S, Ghosh G. A novel DNA recognition mode by the NF-kappa B p65 homodimer. Nat Struct Biol 1998, 5:67-73. 10.1038/nsb0198-67, 9437432.
31. Chen YQ, Sengchanthalangsy LL, Hackett A, Ghosh G. NF-kappaB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets. Structure 2000, 8:419-428. 10.1016/S0969-2126(00)00123-4, 10801482.
32. Britanova LV, Makeev VJ, Kuprash DV. In vitro selection of optimal RelB/p52 DNA-binding motifs. Biochem Biophys Res Commun 2008, 365:583-588. 10.1016/j.bbrc.2007.10.200, 17996728.
33. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 2004, 23:4202-4210. 10.1038/sj.emboj.7600391, 524385, 15470505.
34. Taylor IA, McIntosh PB, Pala P, Treiber MK, Howell S, Lane AN, Smerdon SJ. Characterization of the DNA-binding domains from the yeast cell-cycle transcription factors Mbp1 and Swi4. Biochemistry 2000, 39:3943-3954. 10.1021/bi992212i, 10747782.
35. Chou S, Lane S, Liu H. Regulation of mating and filamentation genes by two distinct Ste12 complexes in Saccharomyces cerevisiae. Mol Cell Biol 2006, 26:4794-4805. 10.1128/MCB.02053-05, 1489142, 16782869.
36. Bianchi ML. Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys 2010, 503:54-65. 10.1016/j.abb.2010.06.026, 20599670.
37. Ronnblom L, Elkon KB. Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol 2010, 6:339-347. 10.1038/nrrheum.2010.64, 20440285.
38. Harada K, Nakanuma Y. Biliary innate immunity in the pathogenesis of biliary diseases. Inflamm Allergy Drug Targets 2010, 9:83-90.
39. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010, 376:1094-1108. 10.1016/S0140-6736(10)60826-4, 20870100.
40. Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169. 10.1111/j.1365-2567.2009.03225.x, 2814458, 20561356.
41. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 2006, 117:740-746; quiz 747. 10.1016/j.jaci.2006.01.038, 16630927.
42. Field S, Udalova I, Ragoussis J. Accuracy and reproducibility of protein-DNA microarray technology. Adv Biochem Eng Biotechnol 2007, 104:87-110.
43. Agilent Technologies eArray. , https://earray.chem.agilent.com/earray/
44. Berger MF, Bulyk ML. Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors. Nat Protoc 2009, 4:393-411. 10.1038/nprot.2008.195, 2908410, 19265799.
45. Beinoraviciute-Kellner R, Lipps G, Krauss G. In vitro selection of DNA binding sites for ABF1 protein from Saccharomyces cerevisiae. FEBS Lett 2005, 579:4535-4540. 10.1016/j.febslet.2005.07.009, 16083878.
46. Angelov D, Lenouvel F, Hans F, Muller CW, Bouvet P, Bednar J, Moudrianakis EN, Cadet J, Dimitrov S. The histone octamer is invisible when NF-kappaB binds to the nucleosome. J Biol Chem 2004, 279:42374-42382. 10.1074/jbc.M407235200, 15269206.
47. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003, 31:3576-3579. 10.1093/nar/gkg585, 169193, 12824369.
48. 1000 Genomes Project. , http://www.1000genomes.org/
49. Hindorff LA, Junkins HA, Hall PN, Mehta JP, Manolio TA. A Catalog of Published Genome-Wide Association Studies. , http://www.genome.gov/gwastudies
50. International HapMap Project. , http://hapmap.ncbi.nlm.nih.gov/
51. Narlikar L, Hartemink AJ. Sequence features of DNA binding sites reveal structural class of associated transcription factor. Bioinformatics 2006, 22:157-163. 10.1093/bioinformatics/bti731, 16267080.
52. Workman CT, Yin Y, Corcoran DL, Ideker T, Stormo GD, Benos PV. enoLOGOS: a versatile web tool for energy normalized sequence logos. Nucleic Acids Res 2005, 33:W389-392. 10.1093/nar/gki439, 1160200, 15980495.